Professional Documents
Culture Documents
O
O
N
H H
H
H
Sulfanilamide
has the structure:
H
2
N
O
6-Methylpterin PABA Glutamate
Folic acid
H
2
N C
O
OH
PABA
(p-aminobenzoic acid)
HN
N N
N
The end of this molecule may
have additional glutamates,
added as -glutamyl residues.
Sulfanilamide competes
with PABA for addition
to 6-methylpterin to
form folic acid.
Figure 7.6 Sulfa drug as structural analog
Sulfanilamide is a competitive inhibitor of metabolic function in microorganisms. It is
an analog of and competes with p-aminobenzoic acid in the synthesis of the vitamin
folic acid.
molecule of 6-methyl pterin with p-aminobenzoic acid
and a molecule of the amino acid glutamic acid. The
presence of sulfanilamide results in the displacement of
p-aminobenzoic acid in microorganisms that synthesize
folic acid. The product thus generated cannot form a
peptide bond with glutamic acid, as the inactive pteri-
dine-sulfa conjugate predominates. Because folic acid is
a mandatory catalyst in the synthesis of purine and
pyrimidines, a microorganism without functional folic
acid would not survive. Animals are unaffected by sul-
fanilamide because they obtain folic acid in their diet
and do not synthesize it from the base constituents.
An understanding of the selective toxicity of sul-
fanilamide led to a concerted search for other chemo-
therapeutic agents. Structural analogs of amino acids,
purines, pyrimidines, and vitamins have been syn-
thesized. Emphasis has been placed on synthesizing
analogs of the bases in DNAand RNA(adenine, thy-
mine, guanine, uracil, and cytosine) in an effort to find
chemical compounds that have antiviral or antitumor
activity. Thousands of compounds have been synthe-
sized, but a limited number have proven effective as
chemotherapeutics.
Some important antiviral agents that have been
developed in recent years, and these include acyclovir
and azidothymidine (AZT). Acyclovir is a structural
analog of deoxyguanosine (Figure 7.7) and can be used
in the treatment of herpes virus infections. When a her-
pes virus (a DNAvirus) multiplies in a cell, the enzyme
thymidine kinase is activated. When acyclovir is pres-
ent, this enzyme gratuitously phosphorylates, resulting
in the formation of an unnatural triphosphate, which
then blocks the DNApolymerase. As a consequence, the
assembly of DNAin viral particles is curtailed.
AZT is an antiviral used in the treatment of AIDS
(acquired immunodeficiency syndrome). This com-
pound inhibits the multiplication of HIV, the retrovirus
that causes AIDS. Unfortunately, neither of these antivi-
ral agents can destroy the nonreplicating intracellular
virus. Both the herpes virus and HIV persist for life in
selected cells within the human host from the time of
infection (see Chapter 29).
Antibiotics as Chemotherapeutics
The term antibiotic, which is familiar to most of us,
was coined by Selman Waksman in 1953. Waksman was
the discoverer of the antibiotic streptomycin, which
played a significant role in the control of tuberculosis.
He defined an antibiotic as . . . a chemical substance,
produced by microorganisms, which has the capacity to
inhibit the growth and even to destroy bacteria and
other microorganisms, in dilute solutions. Antibiotics
that are effective in controlling disease are produced
during growth by certain bacteria, actinomycetes, and
fungi. In fact, the ability to produce antibiotic substances
is widespread in the microbial world, and the group of
bacteria termed the actinomycetes is particularly adept at
producing them. The antibiotics synthesized by actino-
mycetes have remarkable chemical diversity. However,
the first commercially successful antibiotic used in
chemotherapy was produced by a fungus. This antibi-
otic was penicillin and was produced by the fungus
Penicillium notatum (Box 7.1). The search for antibiotic
substances and their industrial production is presented
in Chapter 31. The medical aspects of antibiotics are cov-
ered in Chapters 28 and 29. The present section will pro-
vide a brief discussion of their basic mode of action and
the manner in which infectious organisms become
resistant to them.
Antibiotics are selectively toxic to certain types of liv-
ing cells and less so to others. This selectivity is due
to distinct differences in fundamental physiological
processes in affected cells and unaffected cells. Some
antibiotics are effective against a limited range of bacte-
ria and thus are considered to be narrow-spectrum
antibiotics. Penicillin is an example of this type because
it is mostly effective against gram-positive organisms. A
broad-spectrumantibiotic, such as tetracycline, inhibits
both gram-positive and gram-negative bacteria. Anti-
biotics that inhibit bacteria generally do not inhibit
eukaryotes. Conversely, antibiotics that inhibit eukary-
otes are generally not effective against bacteria. The
Archaea are generally less sensitive to antibacterial
antibiotics.
Antibiotic Actions: Sites and Modes
An antibiotic interferes in some manner with a normal
physiological function in a susceptible cell (Table 7.5).
156 CHAPTER 7
Perry / Staley Lory
Microbiology 2/e, Sinauer Associates
Figure 07.07 Date 12/11/01
CH
2
HO
H
2
N
HOCH
2
H
2
N
N
H
OH
H
H
N
N
C
O
HN
O
N
N
N
C
O
HN
O
Deoxyguanosine
(nucleoside)
Acyclovir
(antiviral)
Figure 7.7 Acyclovir as structural analog
The antiviral agent acyclovir is structurally related to the
nucleoside deoxyguanosine. Phosphorylation of acyclovir
yields an analog of deoxyguanosine triphosphate, which
inhibits the viral DNApolymerase.
The major actions of antibiotics include:
Disruption of cell wall synthesis
Destruction of cell membranes
Interference with some aspect of protein or nucleic
acid synthesis
The most useful antibiotics employed to control
human infections interfere with structural or physio-
logical reactions that are unique to the invading
pathogen. This is possible because the bacteria are phys-
iologically quite different from the eukaryotes.
Consequently, antibacterial antibiotics can exploit these
differences and destroy the invader without significant
harm to the human host.
Control of fungal, protozoan, and viral invaders is
much more difficult because physiological reactions in
these pathogens are quite similar to that in all eukary-
otes including a human host. The physiological differ-
ences among the eukaryotes are simply not so distinct
that these differences can readily be exploited. Thus,
effective antifungal and antiprotozoan agents are gen-
erally toxic to humans. Because viral infections are intra-
cellular, they are also difficult to control with chemother-
apeutic agents. Avirus is synthesized, for the most part,
by the metabolic machinery of the host, and destruction
of this machinery can lead to the destruction of the host.
Several antibiotics and their modes of action are list-
ed in Table 7.5. Penicillin and chemically related antibi-
otics prevent the transpeptidation reaction, which is an
important step in the assembly of the cell wall polymer,
peptidoglycan (see Chapter 4). This results in a weak-
ened cell wall, especially in gram-positive organisms.
Because microorganisms generally live in osmotically
unfavorable environments, one having a weakened cell
wall will take up water and burst, or lyse. Gram-nega-
tive bacteria tend to be less sensitive to penicillin
because their outer envelope can prevent the antibiotic
from reaching the peptidoglycan layer of the cell. The
Archaea that do not have peptidoglycan in their cell wall
are generally unaffected by antibiotics such as penicillin
that interfere with the synthesis of this polymer. Some
of the Archaea are sensitive to selected ionophores that
disrupt membranes (see Table 7.5).
Tyrocidine and polymyxin are both polypeptide
antibiotics that disrupt cell membranes. Both are pro-
duced by bacteria of the genus Bacillus. Tyrocidine is an
ionophore, which destroys selective permeability by
forming channels across the cell membrane, resulting in
leakage of monovalent cations. As a consequence, the
organism cannot establish a proton motive force, and
transport into and out of the cell is impaired. Polymyxin
causes similar cytoplasmic membrane damage. Peptide
antibiotics are not taken internally but are applied topi-
cally to treat skin infections. Enzymes present in the intes-
tinal tract would digest an ingested peptide antibiotic.
Certain antibiotics interfere directly with bacterial
DNA replication. Among these is novobiocin, which
binds directly to the beta subunit of the DNAgyrase
responsible for unwinding supercoiled DNA during
replication. Other antibiotics, such as rifampicin, block
the RNApolymerase involved in transcribing the infor-
mation on the DNAmolecule to make messenger RNA
for protein synthesis (see Chapter 13). Most of these
antibiotics are ineffective in the Archaea.
Many of the clinically useful antibiotics inhibit pro-
tein synthesis in bacteria. Protein synthesis requires
ribosomes, which are structures made up of subunits of
unequal size. Ribosomes are involved in the synthesis
of protein. Bacterial and eukaryotic ribosomes differ in
size, protein content, and ability to bind antibiotics. On
the basis of sedimentation velocity during ultracen-
trifugation, the smaller bacterial ribosome is designated
70S and the larger eukaryotic ribosome size is 80S.
Antibacterial antibiotics that inhibit protein synthe-
sis do so by binding to the bacterial ribosome. This
occurs with the antibiotics tetracycline, chlorampheni-
CONTROL OF MICROBIAL GROWTH 157
The producing organisms and mode of action of several antibiotics
Antibiotic Producer Mode of Action
Penicillin Penicillium spp. Blocks transpeptidation involved in cell wall synthesis
Erythromycin Streptomyces erythreus Binds to 50S ribosomal subunit and stops peptidyltransferase
Chloramphenicol S. venezuelae Binds to ribosomes blocking peptidyltransferase
Rifampicin S. mediterranei Blocks transcribing enzyme RNApolymerase
Novobiocin S. spheroides Binds to a subunit of DNAgyrase
Tyrocidine Bacillus brevis Ionophore disrupts cell membrane integrity and function
Polymyxins B. polymyxa Disrupts membrane transport and function
Streptomycin S. griseus Inhibits 30S ribosomes, blocks amino acid incorporation into peptides
Tetracycline S. aureofaciens Inhibits binding of aminoacyl tRNAto ribosomes
Table 7.5
col, streptomycin, and erythromycin. The antifungal
antibiotic cycloheximide binds to eukaryotic ribosomes
(80S) but not the 70S ribosome that is present in bacte-
ria. Consequently, cycloheximide inhibits fungi but does
not inhibit the growth of bacteria. As humans have 80S
ribosomes, they too would be adversely affected by
cycloheximide. Afew antibiotics, including tetracycline,
can bind to both 70S and 80S ribosomes. However, tetra-
cycline can be used in humans because it does not inhib-
it the synthesis of protein in eukaryotic cells at the con-
centrations used chemotherapeutically. It does impede
wound healing in humans under some circumstances.
RESISTANCE TO ANTIBIOTICS
Antibiotics have been effective in controlling many of
the diseases that have been a scourge to humankind.
Tuberculosis, bacterial pneumonia, syphilis, and many
other human infectious diseases that were once fatal can
now generally be treated with antibiotics. Antibiotics
have been called wonder drugs because they effect a
dramatic cure for what had previously been incurable.
But there is a problem with wonder drugs that
became evident after widespread use.
The extensive use of penicillin as a chemotherapeu-
tic agent led to the evolution of pathogenic bacterial
strains that were unaffected by the drug. These resist-
ant organisms retained their potent pathogenicity but
were no longer controlled by the administration of
penicillin. For example, when penicillin G (see Figure
4.53) was first introduced, virtually all strains of
Staphylococcus aureus were sensitive to the drug. Within
a span of only 10 years, essentially all staph infections
acquired in hospitals were caused by strains that were
resistant to penicillin.
Why do microorganisms become resistant to chemo-
therapeutics? Abundant microbial populations have
existed throughout all of Earths history because
microbes are adaptable. For example, when oxygen
appeared in the atmosphere or the climate became cool-
158 CHAPTER 7
Fortune favors the
prepared mind.
LOUIS PASTEUR
The more I practice,
the luckier I get.
LEE TREVINO
These quotes are a brief summation
of the circumstances that led Sir
Alexander Fleming (18811955) to
the discovery of penicillin. All too
often, scientific advances are attrib-
uted to chance or serendipitous
good fortune, but usually they are
not. More often they are the product
of intuition and hard work. The dis-
covery of penicillin resulted from
Flemings long-held and firm belief
that naturally occurring substances
existed that had useful antimicrobial
properties.
During World War I Fleming
worked in a field hospital in France.
There he treated casualties of battle
and experimented with better ways
of treating deep wounds. The
accepted treatment at that time was
copious quantities of antiseptic
carbolic acid, boric acid, or peroxide.
Unfortunately, in deep wounds
these antiseptics were quickly neu-
tralized by tissue, and serious infec-
tions often followed. Fleming and
his colleague, Sir Almroth Wright
(18611947; a noted developer of
antityphoid vaccine), observed that
wounds carefully cleansed and
treated with minimal antiseptic
healed faster and with fewer serious
infections than wounds treated with
massive amounts of antiseptic. They
believed that stimulation of natural-
defense mechanisms by encourag-
ing the exudation of lymph into the
wound site was particularly effective
in promoting healing. They found
that bathing wounds with a saline
solution was effective in stimulating
the exuding of lymph. The success of
this experimentation convinced
Alexander Fleming that naturally
produced substances could be
employed successfully in the treat-
ment of infectious disease. Fleming
explained to a physician visiting his
laboratory at Boulogne,What we
are looking for is some chemical
substance which can be injected
without danger into the blood
stream for the purpose of destroy-
ing the bacilli of infection, as sal-
varsan destroys the spirochaetes.
Following the war, Fleming
returned to his position at St. Marys
The Antibiotic Age
Sir Alexander Fleming Photo by
Sydney R. Bayne/NLM.
Milestones Box 7.1
er, microbes evolved to survive these new environmen-
tal conditions. Environmental stresses and constraints
became natural selection processes for microbes. Those
that survived carried genes that better adapted them to
serve in the altered conditions. Human control methods
of all types create a challenge to bacteria that leads to
natural selection for those organisms in the environment
that can withstand the prevailing condition. Thus, the
widespread use of penicillin resulted in the selection of
strains that could survive in the presence of the drug.
Some penicillin-resistant strains produce an enzyme,
penicillinase, that destroys the antibiotic.
Microbial resistance to an antibiotic, a chemothera-
peutic agent, or other chemicals such as heavy metals
can occur for several of reasons:
Natural resistance
The organism may lack the structure that the antibi-
otic inhibits, as occurs with mycoplasma, which lacks
cell walls and is thus unaffected by penicillin.
The cell wall structure or cytoplasmic membrane of
an organism may be impermeable to an antibiotic or
other chemical.
Acquired resistance
Aresistant microorganism may produce a substance
that inactivates the antibiotic, as occurs in strains of
Staphylococcus aureus in producing the enzyme peni-
cillinase, which disrupts the penicillin molecule.
Agradual accumulation of mutations in chromosomal
DNAmay result in cellular structures that will not
bind the antibiotic or other chemical. For example, the
gene for transpeptidase synthesis in staphylococci can
mutate so that the enzyme does not bind penicillin.
Another significant problem in antibiotic and other
forms of resistance is the acquisition of bits of extra chro-
mosomal DNAthat carry the information that renders
a microorganism resistant. These bits of DNA are
termed plasmids and can be transferred from cell to
cell (see Chapter 15).
CONTROL OF MICROBIAL GROWTH 159
Hospital in London. As time permit-
ted, he tested various naturally
occurring substances for antibacter-
ial activity. Among the materials he
tested was nasal mucus, and he
observed that addition of mucus to
a suspension of Staphylococcus
aureus led to a rapid clearing of the
turbidity. He discovered that this
clearing resulted from lysis of the
bacterial cells. The factor involved
was an enzyme termed lysozyme
(see Chapter 4). This discovery, made
in 1921, was important scientifically,
but lysozyme was not useful as a
chemotherapeutic agent. It did,
however, offer confirmation to
Fleming that his belief in natural
antibacterials was warranted.
One of Flemings research inter-
ests was Staphylococcus aureus, and
he often had cultures growing on
Petri dishes lying about the lab. One
day while examining some of these
old cultures, he observed that one
was contaminated with a mold and
that bacterial colonies did not devel-
op in the area adjacent to the mold
growth. Fleming was intrigued and
likened the phenomenon to the
action of lysozyme on S. aureus. He
then took a picture of the plate
(shown in the drawing) and wrote
up the observation in his research
notebook. He showed the plate to a
colleague with the remarkTake a
look at that, its interestingthe
kind of thing I like; it may well turn
out to be important.Important,
indeed; the antibacterial substance
produced by the mold (Penicillium
notatum) was penicillin. This ush-
ered in the antibiotic age.Flemings
monumental discovery led eventu-
ally to the conquest of such ancient
scourges as pneumonia, tuberculo-
sis, syphilis, staphylococcal infec-
tions, typhus, and a host of other
human ills.
(continued)
The original Penicilliumplate From
Maurois, Andre. 1959. Life of Sir
Alexander Fleming, E. P. Dutton Co.
Milestones Box 7.1
Flemings drawings and notes
SUMMARY
The role of microorganisms in the cycles of nature is
essentially destructive; human survival often depends
on counteracting their activities.
An understanding of the nature of microorganisms led
to more direct means for controlling them.
Sterilization is the destruction of all viable life forms.
It can be attained by fire, moist heat, dry heat, radia-
tion, filtering, or toxic chemicals.
Microbial death by heating occurs at an exponential
rate. The length of time required to reduce a popula-
tion tenfold is termed the decimal reduction time.
The most effective means for routine sterilization of
media and food is steam under pressure. The common
laboratory apparatus employed for this is the autoclave.
Dry heat at 160C is effective in sterilizing glassware,
pipettes, and other heat-stable material.
Pasteurization is a method for reducing the number
of microorganisms present in milk or other products.
It can destroy selected disease or spoilage-causing
microorganisms.
The wavelengths of light that can cause the death of
microorganisms are ultraviolet light (UV), which dis-
rupts RNA/DNA, and ionizing radiation, which can
potentially harm any constituent of a cell.
Microorganisms have DNArepair systems that can
correct damage caused by radiation.
Filters with pores small enough to retain bacteria can
be employed to sterilize liquids. Anumber of types are
available, but membrane filters are the most widely
used.
Toxic gases such as propylene oxide is used to steril-
ize plastic Petri dishes, filters, and other disposable
material.
Antimicrobial agents may be products of chemical
synthesis, natural products, or a combination of the
two. The favored agent has selective toxicity in that it
destroys the target microbe but produces limited activ-
ity toward other cells.
Adisinfectant is an agent such as phenol that destroys
all living cells on contact. An antiseptic is less potent
and prevents the growth of disease-causing organ-
isms. Merthiolate that is applied to superficial wounds
is an antiseptic.
The minimum inhibitory concentration (MIC) is the
lowest concentration of a germicide that will inhibit a
test organism.
The phenol coefficient is a measure of the effective-
ness of a test compound as compared with phenol.
The first effective chemically synthesized chemother-
apeutic agent was sulfanilamide. An understanding
of the role of this compound in blocking vitamin syn-
thesis in bacteria encouraged the scientific world to
search for other chemical agents that would be effec-
tive against viruses, protozoa, fungi, and cancer.
By definition an antibiotic is a product of microor-
ganisms. Antibiotics have proven to be effective in
controlling human and animal diseases caused by bac-
teria. They generally interfere with metabolic activi-
ties or structures in disease-causing bacteria but do not
interfere with them in a host eukaryote.
The major modes of action of antibiotics include: dis-
rupt cell wall synthesis, destroy cytoplasmic mem-
branes, and disrupt nucleic acid or protein synthesis.
REVIEW QUESTIONS
1. What is the difference between sterilization and pas-
teurization? What agent is most often used in steril-
ization? Why are we so concerned with sterilizing
things?
2. Dry heat is employed to sterilize selected materials.
Name some of the materials best sterilized by dry
heat.
3. What agent is most often used to sterilize air in a
closed room? List what concerns there would be
with other methods.
4. Give some advantages of sterilization by filtration.
How is filtration applied in the laboratory? In
industry?
5. How did Robert Koch determine the effectiveness of
disinfectants? What compound did he find most
effective with this method?
6. How would one calculate a phenol coefficient? Is
this a useful number? List the pros and cons.
7. Sulfanilamide is a classical example of a competitive
inhibitor. How does it function?
8. What are the basic shortcomings of antiviral agents
such as AZT and acyclovir?
9. Why is it so difficult to find effective antiviral and anti-
fungal agents when antibacterials are quite plentiful?
10. Discuss the mode of actions of some common
antibacterials.
160 CHAPTER 7
SUGGESTED READING
Block, S. S., ed. 1991. Disinfection, Sterilization, and
Preservation. 4th ed. Philadelphia: Lea and Febiger.
Favero, M. S. and W. W. Bond. 1991. Sterilization,
Disinfection, and Antisepsis in the Hospital. In A.
Ballows, W. J. Hausler, K. L. Herrmann, H. O. Isenberg
and H. J. Shadomy, eds. Manual of Clinical Microbiology.
5th ed. (pp. 183200). Washington, DC: American Society
for Microbiology.
Hardman, J. G. and L. E. Limbird, eds. 1995. The
Pharmacological Basis of Therapeutics. 9th ed. New York:
Pergamon Press.
Harte, J., C. Holdren, R. Schneider and C. Shirley. 1991.
Toxics Ato Z: AGuide to Everyday Pollution Hazards. Los
Angeles: University of California Press.
Levy, S. B. 1992. The Antibiotic Paradox, How Miracle Drugs
Are Destroying the Miracle. New York: Plenum Press.
CONTROL OF MICROBIAL GROWTH 161